Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F4GG3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,512
Award facts
- Contract value 100% obligated
- $10,512.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,512.49 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Xarelto (rivaroxaban) 20 mg tablets in quantities of 90 units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of January 14, 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime contract vehicle valued through December 31, 2031, which serves as the comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies critical pharmaceutical products and medical supplies to support federal military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse medications across multiple therapeutic domains, including anticoagulants such as Xarelto, specialty pharmaceuticals, generic drugs, vaccines, and related medical commodities. As a vertically integrated player in the pharmaceutical supply chain under parent company Cencora, Inc., AmerisourceBergen consistently competes on a full and open basis to fulfill federal procurement requirements, serving agencies including the Defense Health Agency and supporting the Defense Logistics Agency's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DR26F4GG3?
SPE2DR26F4GG3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F4GG3 worth?
The government has obligated $10,512 on SPE2DR26F4GG3.
Is contract SPE2DR26F4GG3 an order under another contract?
Yes. SPE2DR26F4GG3 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GG3 competed?
The extent of competition for SPE2DR26F4GG3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award